Wells Fargo lowered the firm’s price target on CVS Health to $83 from $84 and keeps an Equal Weight rating on the shares. The firm says that as expected, overall Q4 results were solid despite further MA utilization pressure. CVS believes it is fully caught up on cost trend and has made prudent adjustments to its 2024 guidance. Greater visibility on MA utilization/rates remains key, Wells adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CVS:
- CVS Health price target lowered to $92 from $100 at Morgan Stanley
- A New Cause for Concern: CVS Health Corp Adds a New Corporate Activity and Growth Risk
- CVS Health Corp Earnings Update: Did it Beat Estimate Forecasts?
- CVS Health (NYSE:CVS) Rises after Q4 Earnings Beat
- Unusually active option classes on open February 7th
